Streaming issues? Report here
Pippa Hudson 2019 1500 BW 2 Pippa Hudson 2019 1500 BW 2
Lunch with Pippa Hudson
13:00 - 15:00
volume_up
volume_mute

Up Next: Afternoon Drive with John Maytham
See full line-up
Lunch with Pippa Hudson
13:00 - 15:00
Home
arrow_forward
Local
fiber_manual_record
Business
fiber_manual_record
Politics

'Africa has received less than 1% of global vaccines'

27 July 2021 10:52 AM
Tags:
Africa
Aspen Pharmacare
vaccines
Covid-19 vaccine production
J&J vaccines

Aspen group executive Dr Stavros Nicolaou speaks to Refilwe Moloto about the production of Covid-19 J&J vaccines in Gqeberha.
  • Aspen Pharmacare senior executive Dr Stavros Nicolaou says of the 3.8 billion vaccines distributed globally, Africa has received less than 1%
  • Nicolaou says the only way to solve the problem is to have own capacity locally and distribute to Africa
Image: © Chokniti Khongchum/123rf.com

Aspen Pharmacare yesterday announced the first batch of Johnson & Johnson vaccines produced from its Gqeberha facility are ready to be distributed.

RELATED: Aspen releases first batch of locally finished J&J Covid-19 vaccines for Africa

So far nearly 1.2 million imported J&J shots have been jabbed into arms in SA.

Aspen Pharmacare said it was a seminal moment in that for the first time, a batch of 1.45 million vaccine shots produced in Africa, would be made available to those on the continent completed in South Africa would be distributed to the local market.

Aspen group senior executive Dr Stavros Nicolaou speaks to Refilwe Moloto about their first batch of locally produced Johnson & Johnson vaccines which are now ready for distribution.

This is a historic landmark. There has been significant inequality in the distribution of vaccines globally.

Dr Stavros Nicolaou , Group Senior Executive - Aspen

For example, he says, a little over 3.8 billion Covid vaccines have been administered globally - yet Africa has been the recipient of 1% or less of those.

The only way to solve the problem, is you have to have your own capacity.

Dr Stavros Nicolaou , Group Senior Executive - Aspen

The production will be exclusively for Africa.

Dr Stavros Nicolaou , Group Senior Executive - Aspen

At this point, it is not our product so it is for Johnson & Johnson to determine that.

Dr Stavros Nicolaou , Group Senior Executive - Aspen



27 July 2021 10:52 AM
Tags:
Africa
Aspen Pharmacare
vaccines
Covid-19 vaccine production
J&J vaccines

More from Local

More from Business

More from Politics